RJA
ISEE

Raymond James & Associates’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Raymond James & Associates’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-10,968
Closed -$267K – 4018
2023
Q1 		$267K Sell
10,968
-1,171
-10% -$25.6K ﹤0.01% 3311
2022
Q4 		$260K Buy
+12,139
New +$259K ﹤0.01% 3303
2016
Q4 		– Sell
-24,668
Closed -$1.14M – 3384
2016
Q3 		$1.14M Sell
24,668
-2,783
-10% -$157K ﹤0.01% 1807
2016
Q2 		$1.4M Buy
27,451
+1,389
+5% +$69K ﹤0.01% 1542
2016
Q1 		$1.1M Buy
26,062
+13,292
+104% +$677K ﹤0.01% 1627
2015
Q4 		$1M Sell
12,770
-7,400
-37% -$428K ﹤0.01% 1630
2015
Q3 		$817K Sell
20,170
-464
-2% -$24.6K ﹤0.01% 1696
2015
Q2 		$1.07M Sell
20,634
-558
-3% -$27.8K ﹤0.01% 1698
2015
Q1 		$986K Sell
21,192
-985
-4% -$51.1K ﹤0.01% 1666
2014
Q4 		$995K Buy
22,177
+4,172
+23% +$175K ﹤0.01% 1581
2014
Q3 		$701K Buy
18,005
+6,380
+55% +$250K ﹤0.01% 1706
2014
Q2 		$492K Buy
11,625
+710
+7% +$26.1K ﹤0.01% 1855
2014
Q1 		$389K Sell
10,915
-7,925
-42% -$267K ﹤0.01% 1883
2013
Q4 		$609K Buy
+18,840
New +$559K ﹤0.01% 1579

Other funds holding ISEE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Raymond James & Associates's ISEE Position: Q2 2023 in Review

Raymond James & Associates sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2023, closing a stake of 10,968 shares — an estimated $267K sold.

Raymond James & Associates first reported a position in ISEE in Q4 2013 and held it in 14 quarters. The position peaked at $1.4M in Q2 2016. 256 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.

  • Raymond James & Associates reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Raymond James & Associates sold 10,968 IVERIC bio, Inc. Common Stock shares in Q2 2023, an estimated $267K.
  • Raymond James & Associates first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and held it in 14 quarters.
  • Raymond James & Associates's IVERIC bio, Inc. Common Stock position peaked at $1.4M in Q2 2016.
  • 256 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2023.

Based on Raymond James & Associates's 13F filing for Q2 2023, filed 25 Jul 2023.